Current concepts and novel targets for antiplatelet therapy
Crossref DOI link: https://doi.org/10.1038/s41569-023-00854-6
Published Online: 2023-04-04
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gawaz, Meinrad http://orcid.org/0000-0003-1124-9592
Geisler, Tobias
Borst, Oliver
Text and Data Mining valid from 2023-04-04
Version of Record valid from 2023-04-04
Article History
Accepted: 27 February 2023
First Online: 4 April 2023
Competing interests
: M.G. is the co-inventor of Revacept and is a co-founder of the biotechnology company AdvanceCor. The other authors declare no competing interests.